KR100451414B1 - Indol derivatives and a preparation method thereof - Google Patents

Indol derivatives and a preparation method thereof Download PDF

Info

Publication number
KR100451414B1
KR100451414B1 KR10-2001-0089275A KR20010089275A KR100451414B1 KR 100451414 B1 KR100451414 B1 KR 100451414B1 KR 20010089275 A KR20010089275 A KR 20010089275A KR 100451414 B1 KR100451414 B1 KR 100451414B1
Authority
KR
South Korea
Prior art keywords
formula
compound
reaction
para
added
Prior art date
Application number
KR10-2001-0089275A
Other languages
Korean (ko)
Other versions
KR20030058741A (en
Inventor
조용서
김유승
고훈영
최경일
강경호
배애님
Original Assignee
한국과학기술연구원
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 한국과학기술연구원 filed Critical 한국과학기술연구원
Priority to KR10-2001-0089275A priority Critical patent/KR100451414B1/en
Publication of KR20030058741A publication Critical patent/KR20030058741A/en
Application granted granted Critical
Publication of KR100451414B1 publication Critical patent/KR100451414B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/36Oxygen atoms in position 3, e.g. adrenochrome
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Indole Compounds (AREA)

Abstract

화학식 6의 헤테로고리 화합물 및 그의 제조 방법.Heterocyclic compounds of formula (6) and methods for their preparation.

화학식 6Formula 6

식 중에서, R은 H이거나 Cl, F, Br 및 I에서 선택되는 할로겐 원소이고, Y는 -Ts(토실), -Ms(메실) 또는 -Ac(아세틸)임.Wherein R is H or a halogen element selected from Cl, F, Br and I, and Y is -Ts (tosyl), -Ms (mesyl) or -Ac (acetyl).

Description

인돌 유도체 및 그 제조 방법{INDOL DERIVATIVES AND A PREPARATION METHOD THEREOF}Indole derivatives and preparation method thereof

본 발명은 신규한 인돌 유도체 및 그 제조 방법에 관한 것으로, 더욱 구체적으로 인듐 금속 및 산을 이용하여 알데히드(-CHO)의 알릴화 및 니트로기(-NO2)의 환원 반응을 동시에 수행하여 호모아닐리노알릴릭 알코올을 얻고, 그로부터 일차아민의 보호화 반응과 이차 알코올의 산화 반응을 거쳐 유기 염기 존재하에 고리화 반응을 수행함으로써 인돌 유도체를 제조하는 방법 및 그에 따라 제조된 신규한 인돌 유도체에 관한 것이다.The present invention relates to a novel indole derivative and a method for preparing the same, and more specifically, homoallyl by simultaneously performing allylation of aldehyde (-CHO) and reduction of nitro group (-NO 2 ) using indium metal and acid. The present invention relates to a process for preparing an indole derivative by obtaining a linoallylic alcohol, and then performing a cyclization reaction in the presence of an organic base through a protection reaction of a primary amine and an oxidation reaction of a secondary alcohol. .

일반적으로 인돌 화합물은 많은 의약품 및 농약의 주요 중간체로서 널리 사용되고 있으며, 인돌 유도체를 합성하는 기존의 방법으로는 피셔(Fischer) 인돌 합성법(Chem. Rev.,1942, 30, 69,Heterocyclic Compounds, Vol 3, Wily, New York, 1952, Chapter 1), 마들랭(Madelung) 인돌 합성법 (Chem. Ber.,1912,45, 1128) 및 레이체르트(Reissert) 인돌 합성법 (J. Chem. Soc.,1921,119, 1602) 등이 있다. 본 발명의 화합물과 유사한 구조를 갖는 화합물로는 아래 구조의 화합물이 유일할 것이다(Chem. Ber., 1961, 94, 2960).Generally, indole compounds are widely used as major intermediates of many medicines and pesticides. Existing methods for synthesizing indole derivatives include Fischer indole synthesis method ( Chem. Rev. , 1942, 30 , 69, Heterocyclic Compounds , Vol 3). , Wily, New York, 1952, Chapter 1), Madeleine indole synthesis ( Chem. Ber ., 1912 , 45 , 1128) and Reissert indole synthesis ( J. Chem. Soc ., 1921 , 119 , 1602). As the compound having a structure similar to that of the compound of the present invention, the compound having the following structure will be unique ( Chem. Ber ., 1961, 94, 2960).

그러나, 본 발명자들은 어려운 반응 공정이나 고가의 원료를 사용하지 않고 용이하게 구할 수 있는 출발 물질을 사용하면서 짧은 반응 공정을 거쳐 인돌 유도체를 제조하는 신규한 방법을 예의 연구해온 결과, 본 발명의 방법에 따라 기존의 격렬한 반응 조건과 달리 실온에서 유기 염기와 같이 온화한 반응 조건 하에 높은 수율로 다양한 인돌 유도체를 합성할 수 있다는 것을 발견하였다.However, the present inventors have intensively studied a novel method for preparing an indole derivative through a short reaction process using a starting material which can be easily obtained without using a difficult reaction process or an expensive raw material. Therefore, it has been found that various indole derivatives can be synthesized in high yield under mild reaction conditions such as organic base at room temperature, unlike the existing violent reaction conditions.

따라서, 본 발명의 목적은 인듐 금속 및 산을 이용하여 알데히드(-CHO)의 알릴화 및 니트로기(-NO2)의 환원 반응을 동시에 행하는 방법으로 얻어진 화학식 3의 화합물을 원료 물질로 하여, 친핵성 일차 아민의 보호화 반응, 친핵성 이차 알코올의 산화 반응 및 실온에서 유기 염기 존재하에 고리화 반응을 수행하는 것으로 이루어지는 인돌 유도체의 제조 방법 및 이렇게 제조된 신규한 인돌 화합물을 제공하는 것이다.Accordingly, an object of the present invention is to use a compound of formula (3) obtained by a method of simultaneously performing allylation of aldehyde (-CHO) and reduction reaction of nitro group (-NO 2 ) using an indium metal and an acid as a starting material. To provide a process for preparing an indole derivative comprising the protection of a nuclear primary amine, an oxidation of a nucleophilic secondary alcohol and a cyclization reaction in the presence of an organic base at room temperature, and a novel indole compound thus prepared.

이하에 본 발명을 상세히 설명하면 다음과 같다.Hereinafter, the present invention will be described in detail.

화학식 1의 화합물을 인듐 금속 및 산의 존재하에 화학식 2의 화합물과 반응시켜 알데히드의 알릴화 및 니트로기의 환원 반응을 한 반응 용기 내에서 동시에성취(대한민국 특허 출원 제 37558/2000호)함으로써 화학식 3의 화합물을 얻고, 화학식 3의 화합물 중 아민(-NH2) 그룹을 보호화시켜 화학식 4의 화합물을 얻으며, 이차 알코올의 산화 반응을 통해 얻은 화학식 5의 화합물을 유기 염기 존재하에 화학식 6의 화합물로 고리화하는 제조 방법에 관한 것이다.The compound of formula 1 is reacted with the compound of formula 2 in the presence of an indium metal and an acid to simultaneously achieve an allylation of aldehyde and a reduction reaction of nitro group (Korean Patent Application No. 37558/2000). To obtain a compound of formula (4) by protecting the amine (-NH 2 ) group in the compound of formula (3), and the compound of formula (5) obtained by oxidation of a secondary alcohol to a compound of formula (6) in the presence of an organic base It relates to a production method for cyclization.

상기 화학식 1 내지 화학식 6 및 반응식 1에서, R은 H이거나 Cl, F, Br 및 I에서 선택되는 할로겐 원소이고; X는 Cl, Br 및 I로 구성되는 군에서 선택되는 할로겐 원소이며 Y는 -Ts(토실), -Ms(메실) 또는 -Ac(아세틸)이다.In Formula 1 to Formula 6 and Scheme 1, R is H or a halogen element selected from Cl, F, Br and I; X is a halogen element selected from the group consisting of Cl, Br and I and Y is -Ts (tosyl), -Ms (mesyl) or -Ac (acetyl).

이와 같은 본 발명의 제조 방법을 더욱 상세히 설명하면 다음과 같다.The production method of the present invention will be described in more detail as follows.

화학식 1의 화합물, 화학식 1의 화합물에 대해 2-3 당량의 인듐 금속 및 1-3 당량, 바람직하게는 1.1-2 당량의 화학식 2의 화합물을 적당한 유기 용매에 첨가하고, 혼합물을 교반하면서 천천히 산을 첨가하여 반응을 진행시켰다. 이 때 산은HCl, HBr, 황산, 질산 및 트리플루오로아세트산을 포함하는 강산이며 인듐에 대해 1-2 당량으로 사용한다. 20-100℃에서 산의 첨가 후에 약 10분-1시간 정도 추가로 교반한 후, TLC로 반응의 종결을 확인하였다. 이 반응은 테트라히드로퓨란, 아세토니트릴, N,N'-디메틸아세트아미드, N,N'-디메틸포름알데히드, 메탄올, 에탄올, 이소프로필알코올 및 이들과 물의 혼합 용액 등과 같은 극성 용매하에서 수행된다. 반응 혼합물에 NaHCO3를 첨가한 후, 유기 용매를 사용하여 추출하였다. 그 후 유기층의 건조(예: MgSO4, Na2SO4등) 및 여과, 여과액의 감압 농축, 크로마토그래피 및 재결정 등에 의한 정제를 포함한 통상의 워크-업(work-up)을 통해 화학식 3의 화합물을 합성하였다(본 발명자들에 의한 대한민국 특허 출원 제 37558/2000호).Compounds of formula (1), 2-3 equivalents of indium metal and 1-3 equivalents, preferably 1.1-2 equivalents of compound of formula (2) to a suitable organic solvent are added to a suitable organic solvent and the mixture is slowly The reaction was advanced by adding. In this case, the acid is a strong acid including HCl, HBr, sulfuric acid, nitric acid and trifluoroacetic acid, and is used in 1-2 equivalents with respect to indium. After addition of the acid at 20-100 ° C., the mixture was further stirred for about 10 minutes to 1 hour, and then the reaction was terminated by TLC. This reaction is carried out under polar solvents such as tetrahydrofuran, acetonitrile, N, N'-dimethylacetamide, N, N'-dimethylformaldehyde, methanol, ethanol, isopropyl alcohol and a mixed solution of these and water and the like. NaHCO 3 was added to the reaction mixture, which was then extracted using an organic solvent. And then through conventional work-up including drying the organic layer (e.g., MgSO 4 , Na 2 SO 4, etc.) and filtration, purifying by reduced pressure of the filtrate, chromatography and recrystallization, etc. Compounds were synthesized (Korean Patent Application No. 37558/2000 by the inventors).

화학식 3의 화합물을 3mL의 피리딘에 첨가한 후, 0℃에서 TsCl(파라-톨루엔설포닐 클로라이드) 약 1-3 당량을 천천히 첨가시킨다. 일차아민을 보호화하기 위한 화합물은 토실(-Ts) 그룹, 메실(-Ms) 그룹 또는 아세틸(-Ac) 그룹일 수 있다. 약 3시간 내지 24시간 동안 반응시킨다. 반응 진행 후, 20mL의 물과 10mL의 메틸렌클로라이드를 이용하여 2회 추출한다. 유기 용매와 과도한 피리딘을 MgSO4(또는 Na2SO4)로 건조시키고, 감압하에 여과액을 농축시킨 후 크로마토그래피로 정제시켜 62-78%의 수율로 화학식 4의 화합물을 얻었다. 선택적으로, 화학식 3을 메틸렌클로라이드에 녹인 다음, 약 1-1.5 당량의 TsCl 등을 사용하여 상기와 동일한 방법을 수행하는 것이 또한 가능하다.The compound of formula 3 is added to 3 mL of pyridine and then slowly add about 1-3 equivalents of TsCl (para-toluenesulfonyl chloride) at 0 ° C. Compounds for protecting primary amines may be tosyl (-Ts) groups, mesyl (-Ms) groups or acetyl (-Ac) groups. The reaction is carried out for about 3 to 24 hours. After the reaction proceeds, the mixture is extracted twice using 20 mL of water and 10 mL of methylene chloride. The organic solvent and excess pyridine were dried over MgSO 4 (or Na 2 SO 4 ), the filtrate was concentrated under reduced pressure and purified by chromatography to give the compound of formula 4 in 62-78% yield. Alternatively, it is also possible to dissolve Formula 3 in methylene chloride and then carry out the same process as above using about 1-1.5 equivalents of TsCl and the like.

이렇게 얻은 화학식 4의 화합물을 2mL의 메틸렌 클로라이드에 녹인 다음,PCC(피리디늄 클로로크로메이트) 또는 PDC(피리디늄 디크로메이트) 1-3 당량을 실온에서 천천히 첨가한다. 이 때 PCC 또는 PDC의 바람직한 양은 약 2 당량이다. 또는 선택적으로 스원(Swern's) 산화 반응이나 데스-마틴(Dess-Martin) 페리오디난 산화 반응을 이용하여 이차 알코올을 산화시킬 수 있다. 이 혼합물을 약 4시간 내지 12시간 동안 반응시킨다. 반응 진행 후, 3mL의 디에틸에테르를 첨가하고 셀라이트(celite)를 이용하여 여과시킨다. 유기 용매를 농축시킨 후 크로마토그래피로 정제시켜 65-84%의 수율로 화학식 5의 화합물을 얻었다.The compound of formula 4 thus obtained is dissolved in 2 mL of methylene chloride, and then 1-3 equivalents of PCC (pyridinium chlorochromate) or PDC (pyridinium dichromate) is slowly added at room temperature. At this time, the preferred amount of PCC or PDC is about 2 equivalents. Alternatively, secondary alcohols can be oxidized using Swern's oxidation or Dess-Martin periodinan oxidation. This mixture is allowed to react for about 4 to 12 hours. After the reaction proceeded, 3 mL of diethyl ether was added and filtered using celite. The organic solvent was concentrated and purified by chromatography to give the compound of formula 5 in a yield of 65-84%.

이렇게 얻은 화학식 5의 화합물을 2mL의 메틸렌클로라이드에 녹인 다음, 유기 염기 존재하에 실온에서 반응시킨다. 사용 가능한 유기 염기로는 DBU(1,8-디아자비시클로[5.4.0]운덱-7-엔), DBN(1,5-디아자비시클로[4.3.0]논-5엔), 피리딘 또는 트리에틸아민을 들 수 있다. 유기 염기로서 디이소프로필에틸아민(i-Pr2NEt) 2 당량을 사용하는 것이 바람직하다. 약 10분 내지 5시간 동안 반응시킨 후, 반응 혼합물을 메틸렌클로라이드 10mL를 이용하여 2회 추출한다. 유기층을 아그네슘설페이트로 건조 및 농축시키고, 크로마토그래피에 의해 정제시켜 67-88%의 수율로 화학식 6의 화합물을 얻었다. 반응 온도는 -78 내지 50℃의 범위이고, 바람직하게는 실온 내지 40℃이다.The compound of formula 5 thus obtained is dissolved in 2 mL of methylene chloride and then reacted at room temperature in the presence of an organic base. Organic bases that can be used include DBU (1,8-diazabicyclo [5.4.0] undec-7-ene), DBN (1,5-diazabicyclo [4.3.0] non-5ene), pyridine or tri Ethylamine. Preference is given to using 2 equivalents of diisopropylethylamine ( i- Pr 2 NEt) as the organic base. After reacting for about 10 minutes to 5 hours, the reaction mixture is extracted twice with 10 mL of methylene chloride. The organic layer was dried over magnesium sulfate, concentrated and purified by chromatography to give the compound of formula 6 in a yield of 67-88%. The reaction temperature is in the range of -78 to 50 ° C, preferably room temperature to 40 ° C.

상기 화학식 6의 화합물을 제조하는 과정에서 이성질체가 생성될 수 있으며, 이것은 물리적 방법 또는 키랄 보조제의 사용에 의해 분리 가능하다. 그리고 본 발명은 개별적 이성질체 또는 이들의 라세미체 등을 포함한다.Isomers may be produced in the process of preparing the compound of Formula 6, which may be separated by physical methods or the use of chiral auxiliaries. And the present invention includes individual isomers or racemates thereof.

이하, 아래의 실시예를 들어 본 발명을 보다 상세히 설명할 것이나, 본 발명의 범위가 이들 실시예들에 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to the following examples, but the scope of the present invention is not limited to these examples.

실시예Example

실시예 1. 2-2-히드록시-2-[2-(파라-톨루엔설포닐아미노)페닐]에틸아크릴산 메틸 에스테르Example 1. 2-2-hydroxy-2- [2- (para-toluenesulfonylamino) phenyl] ethylacrylic acid methyl ester

3 mL의 피리딘에 출발물질 2-[2-(2-아미노페닐)-2-히드록시에틸]아크릴산 메틸 에스테르(51.4 mg, 0.23 mmol)를 녹인 다음, 질소 대기하 0℃에서 천천히 파라-톨루엔설포닐클로라이드(88.6 mg, 0.46 mmol)를 첨가하고, 실온에서 약 12 시간 동안 반응시켰다. 반응 혼합물에 물 10 mL를 첨가하고, 메틸렌클로라이드를 사용하여 추출하였다. 유기층을 MgSO4(또는 Na2CO3)를 사용하여 건조시키고, 감압하에 용매를 제거시켰다. 크로마토그래피에 의해 87.4 mg (78%)의 목적 화합물을 얻었다.Dissolve starting material 2- [2- (2-aminophenyl) -2-hydroxyethyl] acrylic acid methyl ester (51.4 mg, 0.23 mmol) in 3 mL of pyridine, and then slowly para-toluenesulfate at 0 ° C. under nitrogen atmosphere. Ponylchloride (88.6 mg, 0.46 mmol) was added and reacted at room temperature for about 12 hours. 10 mL of water was added to the reaction mixture and extracted using methylene chloride. The organic layer was dried using MgSO 4 (or Na 2 CO 3 ) and the solvent was removed under reduced pressure. Chromatography gave 87.4 mg (78%) of the title compound.

1H NMR (300 MHz, CDCl3) δ 2.33 (3H, s), 2.47 (2H, d, J = 6.48 Hz), 3.35 (1H, d, J = 3.18 Hz), 3.76 (3H, s), 4.78 (1H, m), 5.44 (1H, s), 6.15 (1H, d, J = 1.2 Hz), 6.98-7.17 (3H, overlap H), 7.18 (2H, d, J = 8.01 Hz), 7.42 (1H, d, J = 7.95 Hz), 7.67 (2H, d, J = 8.25 Hz), 8.58 (1H, s);13C NMR (CDCl3, 75 MHz) δ 21.9, 41.2, 52.7, 60.8, 122.2, 124.9, 127.5, 127.6, 128.7, 129.4, 130.0, 133.3, 135.5, 136.6, 137.4, 144.1; IR (neat, cm-1) 3482, 3238, 1718, 1710, 1340, 1158, 928. 1 H NMR (300 MHz, CDCl 3 ) δ 2.33 (3H, s), 2.47 (2H, d, J = 6.48 Hz), 3.35 (1H, d, J = 3.18 Hz), 3.76 (3H, s), 4.78 (1H, m), 5.44 (1H, s), 6.15 (1H, d, J = 1.2 Hz), 6.98-7.17 (3H, overlap H), 7.18 (2H, d, J = 8.01 Hz), 7.42 (1H , d, J = 7.95 Hz), 7.67 (2H, d, J = 8.25 Hz), 8.58 (1 H, s); 13 C NMR (CDCl 3 , 75 MHz) δ 21.9, 41.2, 52.7, 60.8, 122.2, 124.9, 127.5, 127.6, 128.7, 129.4, 130.0, 133.3, 135.5, 136.6, 137.4, 144.1; IR (neat, cm -1 ) 3482, 3238, 1718, 1710, 1340, 1158, 928.

실시예 2. 2-2-[2-클로로-6-(파라-톨루엔설포닐아미노)페닐]-2-히드록시에틸아크릴산 메틸 에스테르Example 2. 2-2- [2-chloro-6- (para-toluenesulfonylamino) phenyl] -2-hydroxyethylacrylic acid methyl ester

3 mL의 피리딘에 출발물질 2-[2-(2-아미노-6-클로로페닐)-2-히드록시에틸]아크릴산 메틸 에스테르(38.5mg, 0.15mmol)를 녹인 다음, 질소 대기하 0℃에서 천천히 파라-톨루엔설포닐클로라이드(43.1 mg, 0.23 mmol)을 첨가하고, 실온에서 약 12 시간 동안 반응시켰다. 반응 혼합물에 물 10 mL를 가하고, 메틸렌클로라이드를 사용하여 추출하였다. 유기층을 MgSO4(또는 Na2CO3)를 사용하여 건조시키고, 감압하에 용매를 제거하였다. 크로마토그래피에 의해 46.6 mg (76%)의 목적 화합물을 얻었다.Dissolve starting material 2- [2- (2-amino-6-chlorophenyl) -2-hydroxyethyl] acrylic acid methyl ester (38.5 mg, 0.15 mmol) in 3 mL of pyridine, and then slowly at 0 ° C. under nitrogen atmosphere. Para-toluenesulfonylchloride (43.1 mg, 0.23 mmol) was added and reacted at room temperature for about 12 hours. 10 mL of water was added to the reaction mixture, and the mixture was extracted using methylene chloride. The organic layer was dried using MgSO 4 (or Na 2 CO 3 ) and the solvent was removed under reduced pressure. Chromatography gave 46.6 mg (76%) of the title compound.

1H NMR (CDCl3, 300MHz) δ 2.35 (3H, s), 2.47 (2H, m), 3.79 (3H, s), 4.09 (1H, s), 5.47 (1H, s), 5.49 (1H, m), 6.17 (1H, s), 6.98 (1H, d, J=8.1Hz), 7.07 (1H, t, J=8.1Hz), 7.23 (2H, d, J=8.25Hz), 7.45 (1H, d, J=8.1Hz), 7.75 (2H, d, J=8.22Hz), 9.70 (1H, s,-NH-). 1 H NMR (CDCl 3 , 300 MHz) δ 2.35 (3H, s), 2.47 (2H, m), 3.79 (3H, s), 4.09 (1H, s), 5.47 (1H, s), 5.49 (1H, m ), 6.17 (1H, s), 6.98 (1H, d, J = 8.1 Hz), 7.07 (1H, t, J = 8.1 Hz), 7.23 (2H, d, J = 8.25 Hz), 7.45 (1H, d , J = 8.1 Hz), 7.75 (2H, d, J = 8.22 Hz), 9.70 (1H, s, -NH-).

실시예 3. 2-2-[5-클로로-2-(파라-톨루엔설포닐아미노)페닐]-2-히드록시에틸아크릴산 메틸 에스테르Example 3. 2-2- [5-chloro-2- (para-toluenesulfonylamino) phenyl] -2-hydroxyethylacrylic acid methyl ester

3 mL의 피리딘에 출발물질 2-[2-(2-아미노-5-클로로페닐)-2-히드록시에틸]아크릴산 메틸 에스테르(81.3 mg, 0.32 mmol)를 녹인 다음, 질소 대기하 0℃에서 천천히 파라-톨루엔설포닐클로라이드(121.3 mg, 0.63 mmol)을 첨가하고, 실온에서 약 12 시간 동안 반응시켰다. 반응 혼합물에 물 10 mL를 가하고, 메틸렌클로라이드를사용하여 추출하였다. 유기층을 MgSO4(또는 Na2CO3)를 사용하여 건조시키고, 감압하에 용매를 제거시켰다. 크로마토그래피에 의해 80 mg (62 %)의 목적 화합물을 얻었다.Dissolve starting material 2- [2- (2-amino-5-chlorophenyl) -2-hydroxyethyl] acrylic acid methyl ester (81.3 mg, 0.32 mmol) in 3 mL of pyridine, and then slowly at 0 ° C. under nitrogen atmosphere. Para-toluenesulfonylchloride (121.3 mg, 0.63 mmol) was added and reacted at room temperature for about 12 hours. 10 mL of water was added to the reaction mixture, and the mixture was extracted using methylene chloride. The organic layer was dried using MgSO 4 (or Na 2 CO 3 ) and the solvent was removed under reduced pressure. Chromatography gave 80 mg (62%) of the title compound.

1H NMR (CDCl3, 300MHz) δ 2.36 (3H, s), 2.42 (2H, m, overlap), 3.18 (1H, d, J=2.94 Hz), 3.82 (3H, s), 4.69 (1H, m), 5.54 (1H, s), 6.21 (1H, s), 7.13 (1H, s), 7.15 (1H, overlap), 7.21 (2H, d, J=8.25 Hz), 7.23 (1H, overlap), 7.39 (1H, d, J=9.33 Hz), 7.65 (2H, d, J=8.25 Hz), 8.45 (1H, s, -NH-) 1 H NMR (CDCl 3 , 300 MHz) δ 2.36 (3H, s), 2.42 (2H, m, overlap), 3.18 (1H, d, J = 2.94 Hz), 3.82 (3H, s), 4.69 (1H, m ), 5.54 (1H, s), 6.21 (1H, s), 7.13 (1H, s), 7.15 (1H, overlap), 7.21 (2H, d, J = 8.25 Hz), 7.23 (1H, overlap), 7.39 (1H, d, J = 9.33 Hz), 7.65 (2H, d, J = 8.25 Hz), 8.45 (1H, s, -NH-)

실시예 4. 2-2-옥소-2-[2-(파라-톨루엔설포닐아미노)페닐]에틸아크릴산 메틸 에스테르Example 4. 2-2-oxo-2- [2- (para-toluenesulfonylamino) phenyl] ethylacrylic acid methyl ester

2-2-히드록시-2-[2-(파라-톨루엔설포닐)페닐]에틸아크릴산 메틸 에스테르(33.6 mg, 0.0895 mmol)를 3 mL의 메틸렌클로라이드에 녹인 다음, 질소 대기하 실온에서 실리카겔 20 mg와 PCC(38.6 mg, 0.179 mmol)를 첨가시켰다. 약 16시간 반응 후, 셀라이트를 이용하여 여과시켰다. 감압하에 용매를 제거하고, 크로마토그래피에 의해 정제시킨 결과 28 mg (84 %)의 목적 화합물을 얻었다.2-2-hydroxy-2- [2- (para-toluenesulfonyl) phenyl] ethylacrylic acid methyl ester (33.6 mg, 0.0895 mmol) was dissolved in 3 mL of methylene chloride, and then 20 mg of silica gel at room temperature under nitrogen atmosphere. And PCC (38.6 mg, 0.179 mmol) were added. After the reaction for about 16 hours, the mixture was filtered using Celite. The solvent was removed under reduced pressure and purified by chromatography to give 28 mg (84%) of the title compound.

1H NMR (300 MHz, CDCl3) δ 2.19 (3H, s), 3.87 (3H, s), 3.98 (2H, s), 5.63 (1H, s), 6.4 (1H, s), 7.0-7.88 (8H, overlap H), 11.25 (1H, s);13C NMR (CDCl3, 75 MHz) δ 14.6, 43.1, 52.6, 119.3, 123.0, 124.9, 127.6, 129.3, 130.0,131.6, 133.2, 134.4, 136.6, 140.6, 140.3, 167.1; IR (neat, cm-1) 3124, 1726, 1650, 1334, 1160. 1 H NMR (300 MHz, CDCl 3 ) δ 2.19 (3H, s), 3.87 (3H, s), 3.98 (2H, s), 5.63 (1H, s), 6.4 (1H, s), 7.0-7.88 ( 8H, overlap H), 11.25 (1 H, s); 13 C NMR (CDCl 3 , 75 MHz) δ 14.6, 43.1, 52.6, 119.3, 123.0, 124.9, 127.6, 129.3, 130.0, 131.6, 133.2, 134.4, 136.6, 140.6, 140.3, 167.1; IR (neat, cm −1 ) 3124, 1726, 1650, 1334, 1160.

실시예 5. 2-2-[2-클로로-6-(파라-톨루엔설포닐아미노)페닐]-2-옥소에틸아크릴산 메틸 에스테르Example 5. 2-2- [2-chloro-6- (para-toluenesulfonylamino) phenyl] -2-oxoethylacrylic acid methyl ester

2-2-[2-클로로-6-(파라-톨루엔설포닐)페닐]-2-히드록시에틸아크릴산 메틸 에스테르(46.6mg, 0.11mmol)를 3 mL의 메틸렌클로라이드에 녹인 다음, 질소 대기하 실온에서 실리카겔 20 mg과 PCC (49 mg, 0.23 mmol)를 첨가시켰다. 약 16시간 반응 후, 셀라이트를 이용하여 여과시켰다. 감압하에 용매를 제거하고, 크로마토그래피에 의해 정제시킨 결과. 30 mg (65 %)의 목적 화합물을 얻었다.2-2- [2-Chloro-6- (para-toluenesulfonyl) phenyl] -2-hydroxyethylacrylic acid methyl ester (46.6 mg, 0.11 mmol) was dissolved in 3 mL of methylene chloride, followed by room temperature under nitrogen atmosphere. 20 mg silica gel and PCC (49 mg, 0.23 mmol) were added. After the reaction for about 16 hours, the mixture was filtered using Celite. The solvent was removed under reduced pressure and purified by chromatography. 30 mg (65%) of the title compound were obtained.

1H NMR (300 MHz, CDCl3) δ 2.37 (3H, s), 3.67 (2H, s, -CH2-), 3.87 (3H, s), 5.77 (1H, s), 6.42 (1H, s), 7.07 (1H, d, J=7.02 Hz), 7.24 (3H, dt, overlap of proton), 7.61 (1H, d, J=8.31 Hz), 7.71 (2H, d, J=8.28 Hz), 8.31 (1H, br s, -NH-) 1 H NMR (300 MHz, CDCl 3 ) δ 2.37 (3H, s), 3.67 (2H, s, -CH 2- ), 3.87 (3H, s), 5.77 (1H, s), 6.42 (1H, s) , 7.07 (1H, d, J = 7.02 Hz), 7.24 (3H, dt, overlap of proton), 7.61 (1H, d, J = 8.31 Hz), 7.71 (2H, d, J = 8.28 Hz), 8.31 ( 1H, br s, -NH-)

실시예 6. 2-2-[5-클로로-2-(파라-톨루엔설포닐아미노)페닐]-2-옥소에틸아크릴산 메틸 에스테르Example 6. 2-2- [5-chloro-2- (para-toluenesulfonylamino) phenyl] -2-oxoethylacrylic acid methyl ester

2-2-[5-클로로-2-(파라-톨루엔설포닐)페닐]-2-히드록시에틸아크릴산 메틸 에스테르(80mg, 0.19mmol)를 3 mL의 메틸렌클로라이드에 녹인 다음, 질소 대기하 실온에서 실리카겔 20 mg과 PCC (84 mg, 0.39 mmol)를 첨가시켰다. 약 16시간 반응 후, 셀라이트를 이용하여 여과시켰다. 감압하에 용매를 제거하고, 크로마토그래피에 의해 정제시킨 결과, 67 mg (85 %)의 목적 화합물을 얻었다.2-2- [5-chloro-2- (para-toluenesulfonyl) phenyl] -2-hydroxyethylacrylic acid methyl ester (80 mg, 0.19 mmol) was dissolved in 3 mL of methylene chloride and then at room temperature under nitrogen atmosphere. 20 mg of silica gel and PCC (84 mg, 0.39 mmol) were added. After the reaction for about 16 hours, the mixture was filtered using Celite. The solvent was removed under reduced pressure and the residue was purified by chromatography to give 67 mg (85%) of the title compound.

1H NMR (300 MHz, CDCl3) δ 2.36 (3H, s), 3.76 (3H, s), 3.90 (2H, s), 5.64 (1H, s), 6.39 (1H, s), 7.22 (2H, d, J=8.22 Hz), 7.37 (1H, d, J=2.37 Hz), 7.64 (1H, overlap), 7.68 (2H, d, J=8.22 Hz), 7.80 (1H, s), 11.0 (1H, br s, -NH-) 1 H NMR (300 MHz, CDCl 3 ) δ 2.36 (3H, s), 3.76 (3H, s), 3.90 (2H, s), 5.64 (1H, s), 6.39 (1H, s), 7.22 (2H, d, J = 8.22 Hz), 7.37 (1H, d, J = 2.37 Hz), 7.64 (1H, overlap), 7.68 (2H, d, J = 8.22 Hz), 7.80 (1H, s), 11.0 (1H, br s, -NH-)

실시예 7. 2-[3-옥소-1-(파라-톨루엔설포닐)-2,3-디히드로-Example 7. 2- [3-oxo-1- (para-toluenesulfonyl) -2,3-dihydro- 1H1H -인돌-2-일]프로피온산 메틸 에스테르-Indol-2-yl] propionic acid methyl ester

2-2-옥소-2-[2-(파라-톨루엔설포닐)페닐]에틸아크릴산 메틸 에스테르(63.6 mg, 0.14 mmol)를 3 mL의 메틸렌클로라이드에 녹인 다음, 질소 대기하 실온에서 디이소프로필에틸아민(60μl, 0.34 mmol)를 첨가시켰다. 약 4시간 후, 출발 물질이 사라지면, 3 mL의 H2O를 첨가시켜 반응을 종결하고, 메틸렌클로라이드로 2회 추출하였다. 유기층을 마그네슘설페이트로 건조시키고, 용매를 제거한 다음, 크로마토그래피에 의해 47 mg (88%)이 목적 화합물을 얻었다.Dissolve 2-2-oxo-2- [2- (para-toluenesulfonyl) phenyl] ethylacrylic acid methyl ester (63.6 mg, 0.14 mmol) in 3 mL of methylene chloride, and then diisopropylethyl at room temperature under nitrogen atmosphere. Amine (60 μl, 0.34 mmol) was added. After about 4 hours, when the starting material disappeared, 3 mL of H 2 O was added to terminate the reaction and extracted twice with methylene chloride. The organic layer was dried over magnesium sulfate, the solvent was removed, and then chromatographed to give 47 mg (88%) of the title compound.

1H NMR (300 MHz, CDCl3) δ 1.26 (3H, d, J = 9.03 Hz), 2.35 (3H, s), 3.67 (1H, m), 3.73 (3H, s), 4.22 (1H, d, J = 2.46 Hz), 7.20-8.1 (8H, overlap H of another isomer);13C NMR (CDCl3, 75 MHz) δ 11.6, 21.9, 43.4, 52.6, 68.1, 117.6, 124.6, 125.2, 125.7, 127.8, 130.4, 130.5, 137.5, 145.6, 153.7, 173.7,197.3.; IR (neat, cm-1) 1724, 1602, 1364, 1174.; HRMS (EI) C19H19NO5S에 대한 분석 계산치: 373.0984. 실측치: 373.0991. 1 H NMR (300 MHz, CDCl 3 ) δ 1.26 (3H, d, J = 9.03 Hz), 2.35 (3H, s), 3.67 (1H, m), 3.73 (3H, s), 4.22 (1H, d, J = 2.46 Hz), 7.20-8.1 (8H, overlap H of another isomer); 13 C NMR (CDCl 3 , 75 MHz) δ 11.6, 21.9, 43.4, 52.6, 68.1, 117.6, 124.6, 125.2, 125.7, 127.8, 130.4, 130.5, 137.5, 145.6, 153.7, 173.7, 197.3 .; IR (neat, cm-1) 1724, 1602, 1364, 1174; Analytical Calcd for HRMS (EI) C 19 H 19 NO 5 S: 373.0984. Found: 373.0991.

실시예 8. 2-[4-클로로-3-옥소-1-(파라-톨루엔설포닐)-2,3-디히드로-1Example 8. 2- [4-Chloro-3-oxo-1- (para-toluenesulfonyl) -2,3-dihydro-1 HH -인돌-2-일]프로피온산Indole-2-yl] propionic acid 메틸 에스테르Methyl ester

2-2-[2-클로로-6-(파라-톨루엔설포닐)페닐]-2-옥소에틸아크릴산 메틸 에스테르(29.1 mg, 0.07 mmol)를 3 mL의 메틸렌클로라이드에 녹인 다음, 질소 대기하 실온에서 디이소프로필에틸아민(25μl, 0.14 mmol)을 첨가시켰다. 약 10분 후, 출발 물질이 사라지면, 3 mL의 H2O를 첨가시켜 반응을 종결하고, 메틸렌클로라이드로 2회 추출하였다. 유기층을 마그네슘설페이트로 건조하고, 용매를 제거한 다음, 크로마토그래피에 의해 24.3 mg (84%)의 목적 화합물을 얻었다.2-2- [2-chloro-6- (para-toluenesulfonyl) phenyl] -2-oxoethylacrylic acid methyl ester (29.1 mg, 0.07 mmol) was dissolved in 3 mL of methylene chloride and then at room temperature under nitrogen atmosphere. Diisopropylethylamine (25 μl, 0.14 mmol) was added. After about 10 minutes, when the starting material disappeared, 3 mL of H 2 O was added to terminate the reaction and extracted twice with methylene chloride. The organic layer was dried over magnesium sulfate, the solvent was removed, and then 24.3 mg (84%) of the title compound were obtained by chromatography.

1H NMR (300 MHz, CDCl3) δ 1.32 (3H, d, J = 7.26 Hz), 2.37 (3H, s), 3.50 (1H, m), 3.72 (3H, s), 4.22 (1H, d, J = 2.49 Hz), 7.13 (1H, d, J = 8.19 Hz), 7.23 (3H, overlap of proton), 7.52-7.62 (4H, overlap of protons);13C NMR (CDCl3, 75 MHz) δ 11.4, 21.5, 43.3, 52.2, 67.8, 115.2, 126.1, 127.4, 130.1, 132.1, 132.4, 136.9, 145.5, 154.6, 173.1, 194.0; IR (neat, cm-1) 1730, 1590, 1366, 1174.; HRMS(EI) C19H18ClNO5S에 대한 분석 계산치: 409.0565. 실측치:409.0560. 1 H NMR (300 MHz, CDCl 3 ) δ 1.32 (3H, d, J = 7.26 Hz), 2.37 (3H, s), 3.50 (1H, m), 3.72 (3H, s), 4.22 (1H, d, J = 2.49 Hz), 7.13 (1H, d, J = 8.19 Hz), 7.23 (3H, overlap of protons), 7.52-7.62 (4H, overlap of protons); 13 C NMR (CDCl 3 , 75 MHz) δ 11.4, 21.5, 43.3, 52.2, 67.8, 115.2, 126.1, 127.4, 130.1, 132.1, 132.4, 136.9, 145.5, 154.6, 173.1, 194.0; IR (neat, cm −1 ) 1730, 1590, 1366, 1174; Analytical Calcd for HRMS (EI) C 19 H 18 ClNO 5 S: 409.0565. Found: 409.0560.

실시예 9. 2-[5-클로로-3-옥소-1-(파라-톨루엔설포닐)-2,3-디히드로-1Example 9. 2- [5-chloro-3-oxo-1- (para-toluenesulfonyl) -2,3-dihydro-1 HH -인돌-2-일]프로피온산 메틸 에스테르-Indol-2-yl] propionic acid methyl ester

2-2-[5-클로로-2-(파라-톨루엔설포닐)페닐]-2-옥소에틸아크릴산 메틸 에스테르(67.1 mg, 0.16 mmol)를 3 mL의 메틸렌클로라이드에 녹인 다음, 질소 대기하 실온에서 디이소프로필에틸아민(57.3μl, 0.33 mmol)을 첨가시켰다. 약 40분 후, 출발 물질이 사라지면, 3 mL의 H2O를 첨가시켜 반응을 종결하고, 메틸렌클로라이드로 2회 추출하였다. 유기층을 마그네슘설페이트로 건조하고, 용매를 제거한 다음, 크로마토그래피에 의해 45 mg (67%)의 목적 화합물을 얻었다.2-2- [5-chloro-2- (para-toluenesulfonyl) phenyl] -2-oxoethylacrylic acid methyl ester (67.1 mg, 0.16 mmol) was dissolved in 3 mL of methylene chloride and then at room temperature under nitrogen atmosphere. Diisopropylethylamine (57.3 μl, 0.33 mmol) was added. After about 40 minutes, when the starting material disappeared, 3 mL of H 2 O was added to terminate the reaction and extracted twice with methylene chloride. The organic layer was dried over magnesium sulfate, the solvent was removed, and then chromatographed to give 45 mg (67%) of the title compound.

1H NMR (300 MHz, CDCl3) δ 1.30 (3H, d, J = 6.48 Hz), 2.37 (3H, s), 3.52 (1H, m), 3.71 (3H, s), 4.15 (1H, d, J = 2.64 Hz), 7.23-8.06 (7H, overlap with isomer respectively);13C NMR (CDCl3, 75 MHz) δ 12.1, 21.9, 43.8, 52.7, 68.5, 118.9, 124.1, 127.8, 130.5, 131.2, 132.8, 137.6, 145.9, 151.9, 173.6, 196.1.; IR (neat, cm-1) 1728, 1602, 1366, 1174, 1130.; HRMS(EI) C19H18ClNO5S에 대한 분석 계산치: 407.0594. 실측치: 407.0591. 1 H NMR (300 MHz, CDCl 3 ) δ 1.30 (3H, d, J = 6.48 Hz), 2.37 (3H, s), 3.52 (1H, m), 3.71 (3H, s), 4.15 (1H, d, J = 2.64 Hz), 7.23-8.06 (7H, overlap with isomer respectively); 13 C NMR (CDCl 3 , 75 MHz) δ 12.1, 21.9, 43.8, 52.7, 68.5, 118.9, 124.1, 127.8, 130.5, 131.2, 132.8, 137.6, 145.9, 151.9, 173.6, 196.1 .; IR (neat, cm −1 ) 1728, 1602, 1366, 1174, 1130 .; Analytical Calcd for HRMS (EI) C 19 H 18 ClNO 5 S: 407.0594. Found: 407.0591.

본 발명의 제조 방법은 종래의 방법에 비해 다음과 같은 특징을 갖는다.The manufacturing method of the present invention has the following characteristics as compared to the conventional method.

1)o-니트로벤즈알데히드로부터 짧은 반응 공정을 거쳐 제조할 수 있다.1) It can be prepared through a short reaction process from o -nitrobenzaldehyde.

2) 대부분의 경우 수율이 높다.2) The yield is high in most cases.

3) 다양한 인돌 유도체의 합성이 가능하다.3) Synthesis of various indole derivatives is possible.

본 발명의 제조 방법을 이용하여 유기 염기와 같은 온화한 반응 조건 하에 비교적 단시간으로 의약품 및 농약의 주요 중간체인 인돌 유도체를 제조할 수 있다.The production process of the invention can be used to prepare indole derivatives, which are the major intermediates of pharmaceuticals and pesticides, in a relatively short time under mild reaction conditions such as organic bases.

Claims (4)

하기 화학식 6의 인돌 유도체 또는 그의 이성질체.Indole derivatives of the formula (6) or isomers thereof. 화학식 6Formula 6 식 중에서 R은 H이거나 Cl, F, Br 및 I에서 선택되는 할로겐 원소이고, Y는 -Ts(토실) 또는 -Ms(메실)이다.Wherein R is H or a halogen element selected from Cl, F, Br and I and Y is -Ts (tosyl) or -Ms (mesyl) 화학식 1의 화합물을 인듐 금속 및 산의 존재하에 화학식 2의 화합물과 반응시켜 알데히드의 알릴화 및 니트로기의 환원 반응을 동시에 수행함으로써 화학식 3의 화합물을 얻고, 화학식 3의 화합물 중 아민(-NH2) 그룹을 보호화시켜 화학식 4의 화합물을 얻으며, 화학식 4의 화합물의 이차 알코올을 산화시켜 화학식 5의 화합물을 얻고, 화학식 5의 화합물을 유기 염기 존재하에 고리화시켜 화학식 6의 헤테로고리 화합물로 제조하는 방법.A compound of formula 1 is reacted with a compound of formula 2 in the presence of an indium metal and an acid to simultaneously perform allylation of aldehydes and reduction of nitro groups to obtain a compound of formula 3, and an amine (-NH 2 ) Protecting the group to obtain a compound of formula 4, oxidizing the secondary alcohol of the compound of formula 4 to obtain a compound of formula 5, and cyclizing the compound of formula 5 in the presence of an organic base to prepare a heterocyclic compound of formula How to. 화학식 1Formula 1 화학식 2Formula 2 화학식 3Formula 3 화학식 4Formula 4 화학식 5Formula 5 화학식 6Formula 6 반응식 1Scheme 1 상기 화학식 1 내지 화학식 6 및 반응식 1에서, R은 H이거나 Cl, F, Br 및 I에서 선택되는 할로겐 원소이고, X는 Cl, Br, I로 구성되는 군에서 선택되는 할로겐 원소이며 Y는 -Ts(토실) 또는 -Ms(메실)이다.In Formulas 1 to 6 and Scheme 1, R is H or a halogen element selected from Cl, F, Br and I, X is a halogen element selected from the group consisting of Cl, Br, I and Y is -Ts (Tosyl) or -Ms (mesyl). 제 2 항에 있어서, 이차 알코올의 산화 반응은 PCC(피리디늄 클로로크로메이트) 또는 PDC(피리디늄 디크로메이트)를 이용하거나, 스원(Swern's) 산화 또는 데스-마틴(Dess-Martin) 페리오디난 산화 반응 방법을 이용하는 것이 특징인 방법.The reaction of claim 2, wherein the oxidation of the secondary alcohol is performed using PCC (pyridinium chlorochromate) or PDC (pyridinium dichromate), Swern's oxidation or Dess-Martin periodinan oxidation reaction. Method characterized by using the method. 제 2 항에 있어서, 유기 염기는 디이소프로필에틸아민, DBU(1,8-디아자비시클로[5.4.0]운덱-7-엔), DBN(1,5-디아자비시클로[4.3.0]논-5-엔), 트리에틸아민 또는 피리딘인 것이 특징인 방법.The organic base of claim 2, wherein the organic base is diisopropylethylamine, DBU (1,8-diazabicyclo [5.4.0] undec-7-ene), DBN (1,5-diazabicyclo [4.3.0] Non-5-ene), triethylamine or pyridine.
KR10-2001-0089275A 2001-12-31 2001-12-31 Indol derivatives and a preparation method thereof KR100451414B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR10-2001-0089275A KR100451414B1 (en) 2001-12-31 2001-12-31 Indol derivatives and a preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR10-2001-0089275A KR100451414B1 (en) 2001-12-31 2001-12-31 Indol derivatives and a preparation method thereof

Publications (2)

Publication Number Publication Date
KR20030058741A KR20030058741A (en) 2003-07-07
KR100451414B1 true KR100451414B1 (en) 2004-10-06

Family

ID=32216628

Family Applications (1)

Application Number Title Priority Date Filing Date
KR10-2001-0089275A KR100451414B1 (en) 2001-12-31 2001-12-31 Indol derivatives and a preparation method thereof

Country Status (1)

Country Link
KR (1) KR100451414B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100821936B1 (en) 2006-12-20 2008-04-15 강원대학교산학협력단 Coupling method between carbons in the unsaturated hydrocarbon compound using organo-indium compound as coupling agent

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100778338B1 (en) 2006-09-29 2007-11-22 한국전자통신연구원 Lc quadrature vco having a startup circuit

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3860609A (en) * 1969-05-27 1975-01-14 Novo Terapeutisk Labor As 3-aminoalkyloxyindoles
JPS5379860A (en) * 1976-12-21 1978-07-14 Shionogi & Co Ltd Preparation of 1-acyl-3-indolinone derivs.
JPS53101371A (en) * 1977-02-11 1978-09-04 Ciba Geigy Ag Method of producing novel indolylglyoxylic acid derivative
JPH01139564A (en) * 1987-08-31 1989-06-01 Terumo Corp N-substituted indole ester compound, production thereof, testing composition and testing tool using said compound
KR20020005073A (en) * 2000-07-01 2002-01-17 박호군 Method for the allkylation of aldehyde and reduction of nitro group in one-pot using indium and acid

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3860609A (en) * 1969-05-27 1975-01-14 Novo Terapeutisk Labor As 3-aminoalkyloxyindoles
JPS5379860A (en) * 1976-12-21 1978-07-14 Shionogi & Co Ltd Preparation of 1-acyl-3-indolinone derivs.
JPS53101371A (en) * 1977-02-11 1978-09-04 Ciba Geigy Ag Method of producing novel indolylglyoxylic acid derivative
JPH01139564A (en) * 1987-08-31 1989-06-01 Terumo Corp N-substituted indole ester compound, production thereof, testing composition and testing tool using said compound
KR20020005073A (en) * 2000-07-01 2002-01-17 박호군 Method for the allkylation of aldehyde and reduction of nitro group in one-pot using indium and acid

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100821936B1 (en) 2006-12-20 2008-04-15 강원대학교산학협력단 Coupling method between carbons in the unsaturated hydrocarbon compound using organo-indium compound as coupling agent

Also Published As

Publication number Publication date
KR20030058741A (en) 2003-07-07

Similar Documents

Publication Publication Date Title
US4582918A (en) Preparation of intermediates for (threo)-1-aryl-2-acylamido-3-fluoro-1-propanols
JPH04235968A (en) Production of 2-chloropyridine derivative
JPH08295678A (en) Intermediate for production of 1-(phenyl) -1-hydroxy-2-amino-3-fluoropropane derivative
CN109265386B (en) Novel method for synthesizing 3-acylated indole derivative through C-H activation
FI81339C (en) FOERFARANDE FOER FRAMSTAELLNING AV PYRROLIDINODERIVAT, MELLANPRODUKT OCH DESS FRAMSTAELLNINGSFOERFARANDE.
KR100451414B1 (en) Indol derivatives and a preparation method thereof
KR100209105B1 (en) Aminobutanol derivative and process for the preparation of 3-pyrrolidinol from the same
Tranchant et al. Reaction of vinyl triflates of α-keto esters with primary amines: Efficient synthesis of aziridine carboxylates
KR20060070485A (en) Catalytic asymmetric desymmetrization of prochiral and meso cyclic anhydrides
KR100488444B1 (en) Quinolone derivatives and a preparation method thereof
US4677214A (en) Intermediates for preparation of (threo)-1-aryl-2-acylamido-3-fluoro-1-propanols
EP0070531A2 (en) Tetrahydronaphthoxazoles
KR900003787B1 (en) Process for the preparation of 2-acyl-3,4-dialkoxyanilines
KR19980703584A (en) Alzheimer animal oxadiazine intermediate
US5151544A (en) Intermediates in the preparation of chiral spirofluorenehydantoins
JP2006176531A (en) Optical isomer of optically active benzimidazole derivative
KR100424341B1 (en) A process for preparing 1-Methyl- indazole-3-carboxylic acid
US5457212A (en) Process for the preparation of enantiomerically pure thienopyran derivatives
US6388083B2 (en) Process for the synthesis of (2S)-phenyl-3-piperidone
KR20180124088A (en) Method for converting an S-enantiomer to its racemic form
EP0413832A1 (en) Oxazolidinedione derivatives and production thereof
KR960010351B1 (en) Process for the preparation of benzoxazine derivative
FR2511677A1 (en) PROCESS FOR THE PREPARATION OF ESTERS OF ALCOXYVINCAMINIC ACIDS AND ALCOXYAPOVINCAMINE
EP1140841B1 (en) 3-phenyl-2,6-dioxopiperidin-3-yl propionamide derivatives and method for preparing same
JPH04295469A (en) Method of manufacturing optically active ester of quinoxalinyloxyphenoxypropionic acid

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20090831

Year of fee payment: 6

LAPS Lapse due to unpaid annual fee